Pluristem CEO Zami Aberman Elected to Board of Directors of the Alliance for Regenerative Medicine
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced that Pluristem's Chairman and CEO, Zami Aberman, has been elected to serve on the Board of Directors of the Alliance for Regenerative Medicine (ARM). Based in Washington, D.C., ARM promotes research, development, investment and commercialization of regenerative medicine technologies. Pluristem has been a member of ARM for 3 years and has actively supported the organization's goals. Mr. Aberman joins other prominent leaders in the field of regenerative...
View full press release